Skip to main content

Table 5 Demographics and comorbidities

From: The effect of cumulative glycemic burden on the incidence of diabetic foot disease

Cohort with Charcot arthropathy vs. cohort without, diabetics only
  No Charcot (N = 717) Charcot (N = 54) P value
N %Total N %Total  
Gender      
 Female 370 51.6 26 48.1 0.624
 Male 347 48.4 28 51.9  
Race      0.331
 American Indian or Alaskan Native 1 0.1 0 0  
 Asian 23 3.2 3 5.6  
 Black or African American 179 25 14 25.9  
 Declined 75 10.5 8 14.8  
 Hispanic 7 1 0 0  
 Native Hawaiian or other Pacific Islander 1 0.1 1 1.9  
 Other 96 13.4 8 14.8  
 Unknown 29 4 2 3.7  
 White 306 42.7 18 33.3  
Smoking 255 38.1 21 39.6 0.828
Diabetic nephropathy 62 8.6 2 3.7 0.204
Diabetic retinopathy 96 13.4 5 9.3 0.386
Diabetic neuropathy 76 15.7 7 20 0.103
Hypertension 505 70.4 43 79.6 0.151
Peripheral vascular disease 62 8.6 4 7.4 0.754
Coronary artery disease 180 25.1 16 29.6 0.461
Chronic kidney disease 128 17.9 9 16.7 0.826
Age, year 61 (14)   57 (14)   0.087
BMI 31.7 (7.9)   31.8 (8.7)   0.301
Mean number of HgA1c values drawn 7 (6)   8 (6)   0.512
HgA1c, mean 6.7 (1.5)   6.5 (1.4)   0.401
  1. Significance defined as P < .05. Continuous variables expressed as mean (standard deviation)